WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹26 Cr | ₹4.70 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹4.70 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹17 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 455.60 | |
| Mar2024 | ₹4.70 Cr | -76.27 | |
| Mar2023 | ₹20 Cr | -51.15 | |
| Mar2022 | ₹41 Cr | 142.91 | |
| Mar2021 | ₹17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹788.9 Cr | -0.7% | -9.5% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -0.7% |
-9.5% |
-1.4% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses